The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Open accessAbstract
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology. These recommendations provide a data-supported approach to establishing guidelines. They are based on the following: (1) a formal review and analysis of the recently published world literature on the topic (Medline search up to September 2008); (2) the American College of Physicians' Manual for Assessing Health Practices and Designing Practice Guidelines;1 (3) guideline policies, including the American Association for the Study of Liver Diseases' (AASLD) Policy on the Development and Use of Practice Guidelines and the American Gastroenterological Association's Policy Statement on the Use of Medical Practice Guidelines;2 and (4) the experience of the authors in regard to hepatitis C. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation (Table 1, adapted from the American College of Cardiology and the American Heart association Practice Guidelines).3, 4 AASLD, American Association for the Study of Liver Diseases; ALT, alanine aminotransferase; ANC, absolute neutrophil count; anti-HCV, antibody to HCV; AST, aspartate aminotransferase; CKD, chronic kidney disease; CTP, Child-Turcotte-Pugh; EIA, enzyme immunoassay; ETR, end-of-treatment response; EVR, early virological response; FDA, U.S. Food and Drug Administration; HCV, hepatitis C virus; HIV, human immunodeficiency virus; PCR, polymerase chain reaction; PEG, polyethylene glycol; RVR, rapid virological response; SVR, sustained virological response; ULN, upper limit of normal. The hepatitis C virus (HCV) is a major public health problem and a leading cause of chronic liver disease.5 An estimated 180 million people are infected worldwide.6 In the United States (U.S.), the prevalence of HCV infection between the years 1999 and 2002 was 1.6%, equating to about 4.1 million persons positive for antibody to hepatitis C (anti-HCV), 80% of whom are estimated to be viremic.7 Hepatitis C is the principal cause of death from liver disease and the leading indication for liver transplantation in the U.S.8 Some calculations suggest that mortality related to HCV infection (death from liver failure or hepatocellular carcinoma) will continue to increase over the next two decades.9 The purpose of this document is to provide clinicians with evidence-based approaches to the prevention, diagnosis, and management of HCV infection. The optimal approach to detecting HCV infection is to screen persons for a history of risk of exposure to the virus, and to test selected individuals who have an identifiable risk factor.10 Currently, injection drug use is the primary mode of HCV transmission in the U.S; thus, all persons who use or have used illicit injection drugs in the present or past, even if only once, as well as intranasal drug users who share paraphernalia, should be tested for HCV infection.7, 11, 12 Individuals who have received a blood or blood component transfusion or an organ transplant before 1992 should also be tested. With the introduction of sensitive tests to screen blood donors for HCV antibodies in 1992, transfusion-transmission of HCV has become rare.12, 13 Persons with hemophilia should be tested for HCV infection if blood products were received before 1987, after which time, viral inactivation procedures were implemented.14 Similarly, individuals with unexplained elevations of the aminotransferase levels (alanine and/or aspartate aminotransferase; ALT/AST), those ever on hemodialysis, children born to HCV-infected mothers, or those with human immunodeficiency virus (HIV) infection should be tested for the presence of HCV infection.15-17 Other potential sources of HCV transmission include exposure to an infected sexual partner or multiple sexual partners, exposure among health care workers to HCV-contaminated blood and blood products, and tattooing.12, 15, 18-23 The prevalence of HCV infection is consistently higher among persons with multiple sexual partners, whereas sexual transmission of HCV between monogamous partners is uncommon.11, 18 Thus, although it is prudent to counsel HCV-infected persons to notify their current partners of their HCV status, they should be informed that the risk of sexual transmission is sufficiently low19 that many authorities do not advise the use of barrier protection among monogamous couples.18 Nevertheless, between 1% and 5% of monogam
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–266 of 266
Seeff, L. B. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.005 · Cited by 120
Self-citationHISTOPATHOLOGICAL FEATURES OF HEPATITIS C IN RENAL TRANSPLANT CANDIDATES1
Martin, P., Carter, D., Fabrizi, F., Dixit, V., Conrad, A. J., Artinian, L., Peacock, V., Han, S. H., Wilkinson, A. H., Lassman, C., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00045 · Cited by 118
The neuroimmunology of stress and depression
Raison, C. L., & Miller, A. H. (2001) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2001.0060277 · Cited by 116
Prieto, M., Olaso, V., Verdú, C., Córdoba, J., Gisbert, C., Rayón, M., Carrasco, D., Berenguer, M., Higón, M. D., & Berenguer, J. (1995) · Hepatology · doi:10.1002/hep.1840220207 · Cited by 116
European Paediatric HCV Network (2001) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s0306-5456(00)00088-7 · Cited by 115
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
Sugawara, Y., Makuuchi, M., Matsui, Y., Kishi, Y., Akamatsu, N., Kaneko, J., & Kokudo, N. (2004) · Transplantation · doi:10.1097/01.tp.0000142677.12473.e5 · Cited by 112
Briggs, M. E., Baker, C., Hall, R., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.29303 · Cited by 111
Spontaneous clearance of childhood hepatitis C virus infection
Yeung, L., To, T. M., King, S., & Roberts, E. A. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00873.x · Cited by 110
Human Immunodeficiency Virus Infection, Anemia, and Survival
Moore, R. D. (1999) · Clinical Infectious Diseases · doi:10.1086/520178 · Cited by 106
Outcomes of acute rejection after interferon therapy in liver transplant recipients
Saab, S., Kalmaz, D. M., Gajjar, N. A., Hiatt, J. R., Durazo, F. A., Han, S., Farmer, D. G., Ghobrial, R. M., Yersiz, H., Goldstein, L. I., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20157 · Cited by 105
Sylvestre, D. L., Litwin, A. H., Clements, B. J., & Gourevitch, M. N. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.06.002 · Cited by 104
A comprehensive study of the association between hepatitis C virus and glomerulopathy
Sabry, A. A.-A., Sobh, M. A. K., Irving, W. L., Grabowska, A., Wagner, B. E., Fox, S., Kudesia, G., & Nahas, A. M. E. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.2.239 · Cited by 104
Khuroo, M. S., Khuroo, M. S., & Dahab, S. T. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02208.x · Cited by 103
Foster, G. R., Tudor‐Williams, G., White, J., & Regan, L. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.01036_1.x · Cited by 102
When and how to treat acute hepatitis C?
Licata, A., Bona, D. D., Schepis, F., Shahied, L., Craxı̀, A., & Cammà, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00461-6 · Cited by 101
The management of HCV infected pregnant women and their children European paediatric HCV network
Pembrey, L., Newell, M., Tovo, P., & Collaborators, T. E. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.002 · Cited by 96
Golub, E. T. (2004) · Journal of Heredity · doi:10.1093/jurban/jth114 · Cited by 95
Diabetes mellitus after kidney transplantation: a French multicentre observational study
Kamar, N., Mariat, C., Delahousse, M., Dantal, J., Najjar, A. A., Cassuto, É., Lefrançois, N., Cointault, O., Touchard, G., Villemain, F., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm011 · Cited by 95
Sharma, P., Marrero, J. A., Fontana, R. J., Greenson, J. K., Conjeevaram, H. S., Su, G. L., Askari, F. K., Sullivan, P., & Lok, A. S.-F. (2007) · Liver Transplantation · doi:10.1002/lt.21121 · Cited by 94
Zylberberg, H., Benhamou, Y., Lagneaux, J. L., Landau, A., Chaix, M., Fontaine, H., Bochet, M., Poynard, T., Katlama, C., Pialoux, G., et al. (2000) · Gut · doi:10.1136/gut.47.5.694 · Cited by 92
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
Fontaine, H., Nalpas, B., Poulet, B., Carnot, F., Zylberberg, H., Bréchot, C., & Pol, S. (2001) · Human Pathology · doi:10.1053/hupa.2001.28228 · Cited by 92
High-dose interferon-α2b treatment prevents chronicity in acute hepatitis C
Vogel, W., Graziadei, I. W., Umlauft, F., et al. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02087880 · Cited by 91
Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
Mohan, P., Colvin, C. A., Glymph, C., Chandra, R. R., Kleiner, D. E., Patel, K. M., Luban, N. L. C., & Alter, H. J. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.11.037 · Cited by 90
Chronic Hepatitis C in Patients With Persistently Normal Alanine Transaminase Levels
Shiffman, M. L., Diago, M., Tran, A., Pockros, P. J., Reindollar, R., Prati, D., Rodriguez‐Torres, M., Lardelli, P., Blotner, S. D., & Zeuzem, S. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.002 · Cited by 88
The Liver Biopsy in Chronic Hepatitis C: A View from the Other Side of the Microscope
Kleiner, D. E. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-864781 · Cited by 82
Balasekaran, R., Bulterys, M., Jamal, M. M., Quinn, P. G., Johnston, D. E., SKIPPER, B. J., Chaturvedi, S., & Arora, S. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01084.x · Cited by 80
Westin, J., Lagging, M., Dhillon, A. P., Norkrans, G., Romero, A. I., Pawlotsky, J., Zeuzem, S., Schalm, S. W., Verheij‐Hart, E., Negro, F., et al. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00777.x · Cited by 79
Pretreatment symptoms and dosing regimen predict side‐effects of interferon therapy for hepatitis C
Cotler, Wartelle, Larson, Gretch, Jensen, & Jr, C. (2000) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2000.00215.x · Cited by 76
Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection
European Paediatric Hepatitis C Virus Network Prepared by:, Polywka, S., Pembrey, L., Tovo, P., & Newell, M. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20540 · Cited by 76
Fibrosis progression in initially mild chronic hepatitis C
Boccato, S., Pistis, R., Noventa, F., Guido, M., Benvegnù, L., & Alberti, A. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00683.x · Cited by 73
Natural History of Perinatal Hepatitis C Virus Infection
Palomba, E., Manzini, P. M., Fiammengo, P., Maderni, P., Saracco, G. M., & Tovo, P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.47 · Cited by 73
AASLD position paper: Liver biopsy
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2008) · Hepatology · doi:10.1002/hep.22786 · Cited by 72
Fontaine, H., Vallet‐Pichard, A., Equi-Andrade, C., Nalpas, B., Verkarre, V., Chaix, M., Lebray, P., Sobesky, R., Serpaggi, J., Kreis, H., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000128911.87538.aa · Cited by 71
Helbling, B., Jochum, W., Stamenic, I., Knöpfli, M., Cerny, A., Borovicka, J., Gonvers, J., Wilhelmi, M., Dinges, S., Müllhaupt, B., et al. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00753.x · Cited by 70
Kamar, N., Ribes, D., Izopet, J., & Rostaing, L. P. E. (2006) · Transplantation · doi:10.1097/01.tp.0000238898.14393.c9 · Cited by 68
Airoldi, J. A., & Berghella, V. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000238671.13495.33 · Cited by 67
Marcellin, P., Martinot-Peignoux, M., Elias, A., Branger, M., Courtois, F., Level, R., Erlinger, S., & Benhamou, J. P. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.433 · Cited by 63
Opravil, M., Sasadeusz, J. J., Cooper, D. A., Rockstroh, J. K., Clumeck, N., Clotet, B., Montaner, J., Torriani, F. J., DePamphilis, J. K., & Dieterich, D. T. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815ac47d · Cited by 63
The natural history of chronic hepatitis C infection
Strader, D. B., & Seeff, L. B. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199604000-00006 · Cited by 59
Self-citationHepatitis C transmission by cosmetic tattooing in women
Sun, D., Zhang, F.-G., Geng, Y.-Q., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91172-1 · Cited by 57
Hwang, L., Kramer, J. R., Troisi, C. L., et al. (2006) · Hepatology · doi:10.1002/hep.21252 · Cited by 55
Treatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia
Matthews, G. V., Kronborg, I. J., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427448 · Cited by 55
Nutt, A., Hassan, H. A.-H., Lindsey, J. L., Lamps, L. W., & Raufman, J. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00381-8 · Cited by 53
Tsai, J., Jeng, J., Ho, M., Chang, W., Lin, Z., & Tsai, J. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80004-3 · Cited by 51
ARORA, S., O’Brien, C., Zeuzem, S., Shiffman, M. L., Diago, M., Tran, A., Pockros, P. J., Reindollar, R., Gane, E. J., PATEL, K., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04059.x · Cited by 51
Levine, R. A., Sanderson, S. O., Ploutz-Snyder, R. J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.028 · Cited by 49
Chronic hepatitis C with normal aminotransferase levels
Ahmed, A., & Keeffe, E. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.073 · Cited by 47
Landau, A., Batisse, D., Piketty, C., Jian, R., & Kazatchkine, M. D. (2000) · AIDS · doi:10.1097/00002030-200008180-00025 · Cited by 46
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
Romero‐Gómez, M., Grande, L., Nogales, M. C., Fernández, M., Chavez, M., & Castro, M. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80048-7 · Cited by 44
Clinical management of HCV carriers with normal aminotransferase levels
Puoti, C., Guido, M., Mangia, A., Persico, M., & Prati, D. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00185-3 · Cited by 44
Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT
Jacobson, I. M., Ahmed, F., Russo, M. W., Lebovics, E., Dieterich, D. T., Esposito, S. P., Bach, N., Klion, F. M., Tobias, H., Antignano, L. V., et al. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30049.x · Cited by 43
Prevalence of Hepatitis C–Related Cirrhosis in Elderly Asian Patients Infected in Childhood
D'Souza, R., Glynn, M. J., Ushiro‐Lumb, I., Feakins, R. M., Domizio, P., Mears, L., ALSCED, E., KUMAR, P., Sabin, C. A., & Foster, G. R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00527-6 · Cited by 43
Hepatitis C and hemodialysis: a review
Moreira, R. C., Lemos, M. F., Longui, C. A., & Granato, C. F. H. (2005) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702005000400001 · Cited by 31
Prevalence of hepatitis C virus infection in urban children
El‐Kamary, S. S., Serwint, J. R., Joffe, A., Santosham, M., & DUGGAN, A. K. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00278-6 · Cited by 30
Hepatitis C virus infection acquired in childhood
Camarero, C., Ramos, N., Moreno, A., Asensio, Á., Mateos, M. L., & Roldán, B. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0472-5 · Cited by 28
Marcellini, M., Kondili, L. A., Comparcola, D., Spada, E., Sartorelli, M. R., Palumbo, M., & Rapicetta, M. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199711000-00009 · Cited by 26
Soriano, V., Bravo, R., García‐Samaniego, J., Castilla, J., González, J., Castro, Á., & Llibre, J. M. (1997) · PubMed · Cited by 26
Contreras, A. M., Ruiz, I., Polanco-Cruz, G., Monteón, F., Celis, A., Vázquez, G., Gómez‐Herrera, E., García-Correa, J., Malé-Velázquez, R., & Ruelas, S. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31953-2 · Cited by 25
Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time?
Crockett, S. D., Kaltenbach, T. R., & Keeffe, E. B. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.009 · Cited by 24
Treatment of Hepatitis C in Potential Lung Transplant Candidates
Doucette, K. E., Weinkauf, J. G., Sumner, S., Ens, K., & Lien, D. C. (2007) · Transplantation · doi:10.1097/01.tp.0000264561.18380.22 · Cited by 19
Lemos, L. B., Perez, R. D. M., Lemos, M. M., Lanzoni, V. P., Draibe, S. A., Silva, I. S., Silva, A. E. B., & Ferraz, M. L. G. (2007) · American Journal of Nephrology · doi:10.1159/000100892 · Cited by 13
Sulkowski, M. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318068d0f4 · Cited by 11
Yu, M., Dai, C., Lee, L., Hou, N., Hsieh, M., Huang, J., Lin, Z., Chen, S., Hsieh, M., Wang, L., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01358a.x · Cited by 11
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Metadata
- Authors
- Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B.
- Venue
- Hepatology
- Published
- 2009-04
- Volume
- 49
- Issue
- 4
- Pages
- 1335-1374
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2113864802
- Cited by
- 2,973
- References
- 266
- FWCI
- 141.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.